Covered recipient · General Payments record
LEAH ASHLEY BONAPARTE-DOTTA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,704.63
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.37 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $249.48 | 2 |
| Dompe US, Inc. | $108.30 | 1 |
| ABBVIE INC. | $73.90 | 4 |
| Alcon Laboratories Inc | $73.34 | 3 |
| BIOTISSUE HOLDINGS INC. | $66.86 | 4 |
| Oyster Point Pharma, Inc. | $27.31 | 1 |
| Rayner Intraocular Lenses Limited | $20.98 | 1 |
| Genentech USA, Inc. | $19.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345340 | CMS |
| ABBVIE INC. | $17.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345342 | CMS |
| ABBVIE INC. | $15.53 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345344 | CMS |
| ABBVIE INC. | $17.56 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103345346 | CMS |
| Alcon Vision LLC | $26.16 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110707777 | CMS |
| Alcon Vision LLC | $15.33 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110707775 | CMS |
| Alcon Vision LLC | $31.85 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110707779 | CMS |
| Amgen Inc. | $124.74 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111532708 | CMS |
| Amgen Inc. | $124.74 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111532710 | CMS |
| BIOTISSUE HOLDINGS INC. | $14.06 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148778267 | CMS |
| BIOTISSUE HOLDINGS INC. | $14.07 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148778309 | CMS |
| BIOTISSUE HOLDINGS INC. | $19.03 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148767990 | CMS |
| BIOTISSUE HOLDINGS INC. | $19.70 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148751578 | CMS |
| Dompe US, Inc. | $108.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151409395 | CMS |
| Genentech USA, Inc. | $19.20 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133052877 | CMS |
| Oyster Point Pharma, Inc. | $27.31 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147419818 | CMS |
| Rayner Intraocular Lenses Limited | $20.98 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076273442 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.